Key result
The high-molecular weight adiponectin ratio (HMWR) was a better predictor of insulin resistance than total adiponectin, with a larger AUC.
Why the study?
Does the HMW adiponectin ratio improve the prediction of insulin resistance and metabolic syndrome compared to total adiponectin levels in patients admitted for diabetes treatment or coronary angiography?
Observational (n=298)
Does the HMW adiponectin ratio improve the prediction of insulin resistance and metabolic syndrome compared to total adiponectin levels in patients admitted for diabetes treatment or coronary angiography?
The ratio of high-molecular weight to total adiponectin is a superior biomarker compared to total adiponectin alone for identifying insulin resistance and metabolic syndrome.
Answers are grounded in this paper and cite their sources.
HMWR may outperform total adiponectin for insulin resistance prediction; leaves open its utility for metabolic syndrome screening in diabetes or CAD admissions.
OBJECTIVE: The high-molecular weight (HMW) form of adiponectin, an adipocyte-derived insulin-sensitizing hormone, has been reported to be the most active form of this hormone. We investigated whether measurement of plasma HMW adiponectin levels, using our newly developed enzyme-linked immunosorbent assay system for selective measurement of human HMW adiponectin level, may be useful for the prediction of insulin resistance and metabolic syndrome. RESEARCH DESIGN AND METHODS: A total of 298 patients admitted for diabetes treatment or coronary angiography served as study subjects. Receiver operator characteristic (ROC) curves for the HMW ratio (HMWR; ratio of plasma level of HMW adiponectin to that of total adiponectin) and plasma total adiponectin levels were plotted to predict the presence of insulin resistance and metabolic syndrome. RESULTS: The area under the ROC curve (AUC) of the HMWR values to predict the presence of insulin resistance was significantly larger than that of plasma total adiponectin level in total subjects (0.713 [95% CI 0.620-0.805] vs. 0.615 [0.522-0.708], P = 0.0160). The AUC for the HMWR values to predict the presence of metabolic syndrome was significantly larger than that for plasma total adiponectin levels in men (0.806 [0.747-0.865] vs. 0.730 [0.660-0.800], P = 0.0025) and in women (0.743 [0.659-0.828] vs. 0.637 [0.532-0.742], P = 0.0458). CONCLUSIONS: The HMWR value has better predictive power for the prediction of insulin resistance and metabolic syndrome than plasma total adiponectin level.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2006) conducted an observational in Diabetes or coronary artery disease (n=298). High-molecular weight adiponectin ratio (HMWR) vs. Plasma total adiponectin was evaluated on Prediction of insulin resistance (AUC) (95% CI 0.620-0.805, p=0.0160). The high-molecular weight adiponectin ratio (HMWR) was a better predictor of insulin resistance than total adiponectin, with a larger AUC.
Synapse has enriched 10 related papers. Consider them for comparative context: